Elanco director Anand acquires 642 stock-linked units

The unit count reflects deferred director cash compensation divided by Elanco's $24.61 closing share price on the grant date.

Rhea-AI Filing Summary

Elanco Animal Health Inc. director Kapila K. Anand acquired 642.0277 deferred stock units on September 30, 2026, after electing to defer director cash retainer fees under the Directors' Deferral Plan. Each unit is the economic equivalent of one common share. Her reported holdings after the transaction were 10,721.5916 deferred stock units. The unit count is calculated by dividing deferred cash compensation by the $24.61 closing share price on the grant date.

Insider Trade Summary

Grant/Award: 642.0277 shares

Grant/Award 1 txn

Insider Anand Kapila K

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferred Stock Units F1, F2, F3	642.0277	$22.39	$14K

Holdings After Transaction: Deferred Stock Units — 10,721.5916 contracts (Direct)

Footnotes (3)

1. F1. Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.
2. F2. The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.
3. F3. The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $24.61 on September 30, 2026.

Key Figures

Deferred stock units acquired: 642.0277 deferred stock units Deferred stock units following transaction: 10,721.5916 deferred stock units Closing share price: $24.61 per share

3 metrics

Deferred stock units acquired 642.0277 deferred stock units September 30, 2026

Deferred stock units following transaction 10,721.5916 deferred stock units Kapila K. Anand's reported holdings after the transaction

Closing share price $24.61 per share Grant date; used to calculate the number of deferred stock units

Key Terms

Deferred Stock Units, Directors' Deferral Plan, separation of service

3 terms

Deferred Stock Units financial

"Each Deferred Stock Unit is the economic equivalent of one share"

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

Directors' Deferral Plan financial

"pursuant to the Company's Directors' Deferral Plan"

separation of service financial

"upon the reporting person's separation of service"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many deferred stock units did ELAN director Kapila K. Anand acquire?

Kapila K. Anand acquired 642.0277 deferred stock units on September 30, 2026. She elected to defer director cash retainer fees under Elanco's Directors' Deferral Plan, and her reported holdings after the transaction were 10,721.5916 deferred stock units.

When are ELAN deferred stock units settled?

The deferred stock units will be settled in stock when Kapila K. Anand separates from service on Elanco's Board of Directors. Each unit is the economic equivalent of one share of Elanco common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/01/2026 - 04:04 PM Accepted by SEC EDGAR 10/01/2026 - 04:04 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Anand Kapila K

(Last) (First) (Middle)

C/O ELANCO ANIMAL HEALTH INCORPORATED

450 ELANCO CIRCLE

(Street)

INDIANAPOLIS INDIANA 46221

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock Units(1)(2)	(3)	09/30/2026		A		642.0277		(1)	(1)	Common Stock	642.0277	$22.39(2)(3)	10,721.5916	D

Explanation of Responses:

1. Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

2. The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

3. The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $24.61 on September 30, 2026.

	/s/ Amy C. Seidel, as Attorney-in-Fact for Kapila K. Anand	10/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)